D-1542-2020 Class II Terminated
FDA drug recall D-1542-2020 was initiated by Par Pharmaceutical Inc. on Aug 10, 2020 and is designated Class II. Reason for recall: Failed Impurity /Degradation Specifications The recall status is terminated (terminated Jun 7, 2021). Affected quantity: 11,347 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 2, 2020
- Initiation Date
- Aug 10, 2020
- Termination Date
- Jun 7, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,347 bottles
Product description
BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
Reason for recall
Failed Impurity /Degradation Specifications
Distribution pattern
Product was distributed to 9 major distributors throughout the United States.
Code information
Lot # 32091002, exp. date May 2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1542-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026